Novonix (NVNXF) Short term Debt (2020 - 2025)

Novonix has reported Short term Debt for 6 years, with the latest figure at $62.1 million in Q4 2025.

• For the quarter ending Q4 2025, Short term Debt rose 89.38% year-over-year to $62.1 million; the trailing twelve-month figure through Dec 2025 stood at $62.1 million (up 89.38% YoY), and the FY2025 full-year result was $62.1 million, up 89.38% from the prior year.
• Short term Debt for Q4 2025 stood at $62.1 million, down from $91.2 million in the prior quarter.
• The five-year high for Short term Debt was $91.2 million in Q2 2025, with the low at $213351.5 in Q2 2021.
• Historically, Short term Debt has averaged $35.2 million across 5 years, with a median of $32.8 million in 2024.
• Annual changes were most pronounced in 2023 — Short term Debt jumped 5865.26% — and 2024, when it sank 51.01%.
• Novonix's Short term Debt stood at $35.2 million in 2021, then slumped by 97.0% to $1.1 million in 2022, then fell by 17.95% to $866278.0 in 2023, then surged by 3683.46% to $32.8 million in 2024, then jumped by 89.38% to $62.1 million in 2025.
• The last three Short term Debt figures came in at $62.1 million (Q4 2025), $91.2 million (Q2 2025), and $32.8 million (Q4 2024), per Business Quant data.